BioAtla, Inc. (BCAB) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
BCAB Historical Performance
Short-Term Returns
BCAB Stock Price Trajectory (2020–2026)
As of May 8, 2026, BioAtla, Inc. (BCAB) trades at $4.35, representing a -80.6% return over the past year. The stock has delivered a -99.8% total return over five years (-71.6% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $3,831.50 on March 19, 2021. From this peak, BCAB has corrected -99.9%, currently trading 81% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers IMVT (+96.1% 1Y), RCUS (+209.6% 1Y), and AGEN (+27.1% 1Y), BCAB has underperformed the peer group average. Compare BCAB vs IMVT →
BCAB Historical Price Data (2025–2026)
Showing 30 of 1,354 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 4.43 | 4.58 | 4.26 | 4.35 | 10K | -3.33% |
| 2026-05-06 | 4.69 | 4.73 | 4.46 | 4.50 | 20K | +2.74% |
| 2026-05-05 | 4.82 | 4.82 | 4.30 | 4.38 | 51K | -6.81% |
| 2026-05-04 | 4.14 | 4.81 | 4.14 | 4.70 | 53K | +10.07% |
| 2026-05-01 | 4.16 | 4.35 | 4.14 | 4.27 | 28K | +1.43% |
| 2026-04-30 | 4.13 | 4.30 | 3.92 | 4.21 | 13K | +4.21% |
| 2026-04-29 | 4.40 | 4.41 | 3.97 | 4.04 | 20K | -6.05% |
| 2026-04-28 | 4.52 | 4.75 | 4.30 | 4.30 | 33K | -4.66% |
| 2026-04-27 | 4.85 | 5.21 | 4.51 | 4.51 | 33K | -7.39% |
| 2026-04-24 | 5.18 | 5.18 | 4.74 | 4.87 | 18K | -5.62% |
| 2026-04-23 | 5.83 | 5.83 | 4.98 | 5.16 | 40K | -11.64% |
| 2026-04-22 | 5.68 | 5.99 | 5.52 | 5.84 | 13K | +3.55% |
| 2026-04-21 | 5.85 | 6.14 | 5.23 | 5.64 | 67K | -0.88% |
| 2026-04-20 | 4.59 | 5.69 | 4.58 | 5.69 | 144K | +23.97% |
| 2026-04-17 | 4.82 | 4.91 | 4.56 | 4.59 | 28K | -6.52% |
| 2026-04-16 | 4.56 | 5.00 | 4.31 | 4.91 | 40K | +8.87% |
| 2026-04-15 | 4.25 | 4.53 | 4.25 | 4.51 | 22K | +5.62% |
| 2026-04-14 | 4.43 | 4.45 | 4.20 | 4.27 | 21K | -0.93% |
| 2026-04-13 | 4.50 | 5.22 | 4.31 | 4.31 | 49K | -3.36% |
| 2026-04-10 | 4.44 | 4.59 | 4.33 | 4.46 | 19K | -1.33% |
| 2026-04-09 | 4.39 | 4.68 | 4.35 | 4.52 | 37K | +1.80% |
| 2026-04-08 | 4.80 | 4.90 | 4.20 | 4.44 | 71K | -4.72% |
| 2026-04-07 | 5.37 | 5.37 | 3.92 | 4.66 | 258K | -17.52% |
| 2026-04-06 | 6.52 | 6.52 | 5.42 | 5.65 | 133K | -13.34% |
| 2026-04-02 | 6.85 | 6.94 | 6.38 | 6.52 | 21K | -3.12% |
| 2026-04-01 | 6.21 | 6.90 | 6.00 | 6.73 | 60K | -16.40% |
| 2026-03-31 | 8.00 | 8.20 | 7.25 | 8.05 | 28K | +4.55% |
| 2026-03-30 | 8.05 | 8.08 | 7.65 | 7.70 | 12K | +0.52% |
| 2026-03-27 | 7.80 | 8.45 | 7.53 | 7.66 | 16K | -9.88% |
| 2026-03-26 | 7.72 | 8.50 | 7.50 | 8.50 | 15K | +7.59% |
See BCAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BCAB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BCAB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBCAB — Frequently Asked Questions
Quick answers to the most common questions about buying BCAB stock.
How has BCAB stock performed recently?
BCAB declined -80.6% over the past year, below its 5-year annualized CAGR of -71.6%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is BCAB's all-time high price?
BioAtla, Inc. reached $3831.50 on 2021-03-19. The 52-week high is $71.50. Current 1-year return of -80.6% places the stock further from historical peaks.
Where can I download BCAB historical price data?
This page provides BCAB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.